Related Experiment Videos
Thrombolytic eligibility
C J Ellis1, J K French, H D White
1Department of Medicine, Auckland Hospital, New Zealand.
Insights
Thrombolytic therapy benefits patients with ischemic chest pain and ST elevation or bundle branch block on ECG. This treatment is recommended for specific patient subsets, including those with inferior myocardial infarction and delayed presentation.
Area of Science:
- Cardiology
- Emergency Medicine
- Pharmacology
Background:
- Ischemic chest pain requires prompt diagnosis and treatment.
- Electrocardiogram (ECG) findings guide the decision for thrombolytic therapy.
- The Fibrinolytic Therapy Trialists' Collaborative Group established benefits for specific patient groups.
Purpose of the Study:
- To evaluate thrombolytic eligibility in various patient subsets presenting with ischemic chest pain.
- To explore benefits in patients with inferior myocardial infarction.
- To confirm treatment benefits for patients presenting 6-12 hours after symptom onset.
Main Methods:
- Analysis of data from the Fibrinolytic Therapy Trialists' Collaborative Group.
- Review of ECG criteria for thrombolytic therapy eligibility.
- Examination of treatment outcomes in specific patient subgroups.
Main Results:
- Patients with ischemic chest pain, ST elevation or bundle branch block on ECG benefit from thrombolytic therapy.
- Therapy is beneficial for patients with inferior myocardial infarction.
- Patients presenting 6-12 hours after symptom onset also show treatment benefits.
Conclusions:
- Thrombolytic therapy should be considered for eligible patients regardless of specific conditions.
- Diabetic patients, elderly patients, menstruating women, and those who have undergone cardiopulmonary resuscitation should not be routinely excluded.
- ECG interpretation remains crucial for guiding thrombolytic treatment decisions.
Abstract:
The Fibrinolytic Therapy Trialists' Collaborative Group has demonstrated that patients without clear contraindications who present with ischaemic chest pain within 12 hours of the onset of symptoms and who have ST segment elevation or bundle branch block on their electrocardiogram (ECG), will benefit from thrombolytic therapy. Therefore the treatment of patients presenting with ischaemic chest pain is guided by the initial ECG. This paper addresses the question of thrombolytic eligibility in several subsets of patients who may benefit from treatment. It also explores the data which confirm the benefit for patients presenting with an inferior myocardial infarction and for those presenting from six-12 hours after the onset of symptoms. In conclusion, thrombolytic therapy should not be routinely withheld from diabetic or elderly patients, menstruating women and patients who have had cardiopulmonary resuscitation.